Irradiations-induced telomerase activity and the risk of lung cancer: A pilot case-control study

Cancer

Volumn 109, Issue 6, 2007, Pages 1157-1163

  Chen, Meng ^a   Gu, Jian ^a   Xing, Jinliang ^a   Spitz, Margaret R ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Lung cancer; Susceptibility; Telomerase activity

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; GAMMA IRRADIATION; HUMAN; HUMAN CELL; LUNG CANCER; MALE; PERIPHERAL LYMPHOCYTE; PILOT STUDY; PRIORITY JOURNAL; RISK FACTOR; CASE CONTROL STUDY; ENZYMOLOGY; GAMMA RADIATION; LUNG TUMOR; LYMPHOCYTE; MIDDLE AGED; RADIATION EXPOSURE; RISK;

AGED; CASE-CONTROL STUDIES; FEMALE; GAMMA RAYS; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; PILOT PROJECTS; RISK; TELOMERASE;

EID: 33947211248     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22493     Document Type: Article

References (43)

1. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 1989;59:521-529.
2. Bailey SM, Murnane JP. Telomeres, chromosome instability and cancer. Nucleic Acids Res. 2006;34:2408-2417.
3. Pendino F, Tarkanyi I, Dudognon C, et al. Telomeres and telomerase: Pharmacological targets for new anticancer strategies? Curr Cancer Drug Targets. 2006;6:147-180.
4. Kim NW, Kim NW, Piatyszek MA, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011-2015.
5. Herbert B, Pitts AE, Baker SI, et al. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci U S A. 1999;96:14276-14281.
6. Kondo Y, Kondo S, Tanaka Y, Haqqi T, Barna BP, Cowell JK. Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis. Oncogene. 1998;16:2243-2248.
7. Hahn WC, Stewart SA, Brooks MW, et al. Inhibition of telomerase limits the growth of human cancer cells. Nat Med. 1999;5:1164-1170.
8. Klapper W, Qian W, Schulte C, Parwaresch R. DNA damage transiently increases TRF2 mRNA expression and telomerase activity. Leukemia. 2003;17:2007-2015.
9. Chin L, Artandi SE, Shen Q, et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 1999;97:527-538.
10. Gu J, Spitz MR, Zhao H, et al. Roles of tumor suppressor and telomere maintenance genes in cancer and aging-an epidemiological study. Carcinogenesis. 2005;26:1741-1747.
11. Leteurtre F, Li X, Gluckman E, Carosella ED. Telomerase activity during the cell cycle and in gamma-irradiated hematopoietic cells. Leukemia. 1997;11:1681-1689.
12. Hande MP, Balajee AS, Natarajan AT. Induction of telomerase activity by UV-irradiation in Chinese hamster cells. Oncogene. 1997;15:1747-1752.
13. Hande MP, Lansdorp PM, Natarajan AT. Induction of telomerase activity by in vivo X-irradiation of mouse splenocytes and its possible role in chromosome healing. Mutat Res. 1998;404:205-214.
14. Neuhof D, Ruess A, Wenz F, Weber KJ. Induction of telomerase activity by irradiation in human lymphoblasts. Radiat Res. 2001;155:693-697.
15. Fajkus J. Detection of telomerase activity by the TRAP assay and its variants and alternatives. Clin Chim Acta. 2006;371:25-31.
16. Hiyama E, Hiyama K. Telomerase as tumor marker. Cancer Lett. 2003;194:221-233.
17. Shay JW, Wright WE. Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov. 2006;5:577-584.
18. Wu X, Amos CI, Zhu Y, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003;95:1211-1218.
19. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 1995;85:2315-2320.
20. Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol. 1995;155:3711-3715.
21. Tu W, Zhang DK, Cheung PT, Tsao SW, Lau YL. Effect of insulin-like growth factor 1 on PHA-stimulated cord blood mononuclear cell telomerase activity. Br J Haematol. 1999;104:785-794.
22. Tatsuma T, Goto S, Kitano S, Lin YC, Lee CM, Chen CL. Telomerase activity in peripheral blood for diagnosis of hepatoma. J Gastroenterol Hepatol. 2000;15:1064-1070.
23. Sapi E, Okpokwasili NI, Rutherford T. Detection of telomerase-positive circulating epithelial cells in ovarian cancer patients. Cancer Detect Prev. 2002;26:158-167.
24. Lee BJ, Wang SG, Choi JS, Lee JC, Goh EK, Kim MG. The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patients. Am J Clin Oncol. 2006;29:163-167.
25. Ohali A, Avigad S, Cohen IJ, et al. Association between telomerase activity and outcome in patients with nonmetastatic Ewing family of tumors. J Clin Oncol. 2003;21:3836-3843.
26. Koyanagi K, Ozawa S, Ando N, Kitagawa Y, Ueda M, Kitajima M. Clinical significance of telomerase activity in peripheral blood of patients with esophageal squamous cell carcinoma. Ann Thorac Surg. 2002;73:927-932.
27. Gauthier LR, Granotier C, Soria JC, et al. Detection of circulating carcinoma cells by telomerase activity. Br J Cancer. 2001;84:631-635.
28. Soria JC, Gauthier LR, Raymond E, et al. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients. Clin Cancer Res. 1999;5:971-975.
29. Ge P, Zhang B, Zhang J, Gao Z, He W. Telomerase activity of peripheral blood mononuclear cells from patients with laryngeal carcinoma. Am J Clin Oncol. 2004;27:191-194.
30. Yamada O, Motoji T, Mizoguchi H. Up-regulation of telomerase activity in human lymphocytes. Biochim Biophys Acta. 1996;1314:260-266.
31. Buchkovich KJ, Greider CW. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell. 1996;7:1443-1454.
32. Kosciolek BA, Rowley PT. Human lymphocyte telomerase is genetically regulated. Genes Chromosomes Cancer. 1998;21:124-130.
33. Zhao H, Spitz MR, Tomlinson GE, Zhang H, Minna JD, Wu X. Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer. Cancer Res. 2001;61:7819-7824.
34. Bondy ML, Wang LE, El-Zein R, et al. Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst. 2001;93:1553-1557.
35. Schabath MB, Spitz MR, Grossman HB, et al. Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst. 2003;95:540-547.
36. Shao L, Lin J, Huang M, Ajani JA, Wu X. Predictors of esophageal cancer risk: assessment of susceptibility to DNA damage using comet assay. Genes Chromosomes Cancer. 2005;44:415-422.
37. Natarajan TG, Ganesan N, Carter-Nolan P, Tucker CA, Shields PG, Adams-Campbell LL. gamma-Radiation-induced chromosomal mutagen sensitivity is associated with breast cancer risk in African-American women: caffeine modulates the outcome of mutagen sensitivity assay. Cancer Epidemiol Biomarkers Prev. 2006;15:437-442.
38. Buchholz TA, Wu X. Radiation-induced chromatid breaks as a predictor of breast cancer risk. Int J Radiat Oncol Biol Phys. 2001;49:533-537.
39. Wu X, Roth JA, Zhao H, et al. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res. 2005;65:349-357.
40. Shats I, Milyavsky M, Tang X, et al. p53-dependent downregulation of telomerase is mediated by p21waf1. J Biol Chem. 2004;279:50976-50985.
41. Kusumoto M, Ogawa T, Mizumoto K, et al. Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells. Clin Cancer Res. 1999;5:2140-2147.
42. Kanaya T, Kyo S, Hamada K, et al. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. J Clin Cancer Res. 2000;6:1239-1247.
43. Xu D, Wang Q, Gruber A, et al. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene. 2000;19:5123-5133.